New Additions to Drugs.com for 2002
We update the Drugs.com database on a regular cycle. The following new drug information was added in 2002:
Jan 1, 2002 - Abilify (aripiprazole) is a psychotropic drug indicated for the treatment of schizophrenia, bipolar disorder, adjunctive treatment of major depressive disorder and treatment of irritability associated with autistic disorder.
Jan 1, 2002 - (nitazoxanide) antiprotozoal agent. Used to treat diarrhea in children caused by the protozoa Cryptosporidium parvum and Giardia lamblia.
Jan 1, 2002 - Avandamet (metformin and rosiglitazone) is a biguanide and thiazolidinedione combination indicated to improve glycemic control in patients with type 2 diabetes.
Jan 1, 2002 - Avodart (dutasteride) is a 5-alpha-reductase inhibitor indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH).
Jan 1, 2002 - Benicar (olmesartan medoxomil) is an angiotensin II receptor antagonist for the treatment of hypertension.
Jan 1, 2002 - (urofollitropin) a purified form of a naturally occurring hormone called follicle-stimulating hormone (FSH). Used to stimulate a follicle (egg) to develop and mature when a woman desires pregnancy and her ovaries can produce a follicle but hormonal stimulation is not sufficient to make the follicle mature. Also used to stimulate the development of multiple eggs for in vitro fertilization.
Jan 1, 2002 - (DTaP vaccine) vaccine for diphtheria, tetanus, and pertussis (DTaP), which helps the body to develop immunity to the disease.
Jan 1, 2002 - (rasburicase) increases the rate at which uric acid is broken down in the body. Rasburicase is used to treat increased levels of uric acid caused by the breakdown of tumors during treatment for some types of cancer.
Jan 1, 2002 - (oxaliplatin) a cancer (antineoplastic) medication. Interferes with and slows the growth and spread of cancer cells in the body. Used in the treatment of colon and rectum cancer, often with other anti-cancer medicines or when other treatments have not worked or stopped working.
Jan 1, 2002 - Faslodex (fulvestrant) is an estrogen receptor antagonist indicated for the treatment of hormone receptor positive metastatic breast cancer.
Jan 1, 2002 - (teriparatide) man-made form of the naturally occurring hormone parathyroid. Teriparatide forms new bone, increases bone mineral density and bone strength, and as a result, reduces the chance of getting a broken bone. Used to treat men and women with osteoporosis who are at high risk for bone fractures.
Jan 1, 2002 - (adefovir) used to treat hepatitis B. Adefovir is an antiviral medication which prevents replication of the hepatitis B virus in the body.
Jan 1, 2002 - Humira (adalimumab) is a recombinant human IgGl monoclonal antibody specific for human tumor necrosis factor (TNF) indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, psoriasis, juvenile idiopathic arthritis, ulcerative colitis and hidradenitis suppurativa.
Jan 1, 2002 - (eplerenone) blocks the actions of the hormone aldosterone in the body. Used to lower high blood pressure.
Jan 1, 2002 - (escitalopram) a selective serotonin reuptake inhibitor. Escitalopram affects chemicals in the brain that may become unbalanced and cause depression. Used to treat depression.
Jan 1, 2002 - (glipizide and metformin) used with diet and exercise to treat non-insulin-dependent (type 2) diabetes. Metformin reduces the amount of glucose (sugar) produced by the liver; reduces the amount of glucose absorbed from food through the stomach; and makes the insulin produced by the body work better to reduce the amount of glucose already in the blood. Glipizide is in a class of drugs called sulfonylureas, and helps control blood sugar levels by stimulating the pancreas to release insulin into the blood.
Jan 1, 2002 - (pegfilgrastim) a protein that stimulates production of white blood cells, important for protecting the body from infection. Used to increase white blood cells and therefore decrease the risk of infection in patients with non-myeloid (not bone marrow) cancers while receiving cancer chemotherapy (drugs).
Jan 1, 2002 - (nitisinone) a tyrosine degradation inhibitor. Used along with a special diet to treat hereditary tyrosinemia, type 1. This disease is caused by too much tyrosine in the blood. It may cause damage to the liver, kidneys, eyes, skin, and nervous system. Treatment with nitisinone and diet may slow the disease, but it will not cure it.
Jan 1, 2002 - (whooping cough) , polio, and tetanus (lockjaw) vaccine. Exposes the individual to a small amount of the bacteria or virus (or to a protein from the bacteria or virus) and causes the body to develop immunity to the disease.
Jan 1, 2002 - Pegasys (peginterferon alfa-2a) is a covalent conjugate of recombinant alfa-2a interferon indicated for the combination treatment of adults with chronic hepatitis C.
Jan 1, 2002 - (pantoprazole) decreases the amount of acid produced in the stomach. Used to treat damage to the esophagus associated with gastroesophageal reflux disease (GERD).
Jan 1, 2002 - (interferon beta-1a) used to treat the relapsing forms of multiple sclerosis (MS). Will not cure MS, but it may slow some disabling effects and decrease the number of relapses of the disease. Also used to treat genital warts.
Jan 1, 2002 - (eletriptan) a migraine headache medicine, in a class of drugs called serotonin receptor agonists. They are believed to work by causing vasoconstriction (narrowing) of arteries and veins that supply blood to the head. Used to treat migraine headaches that are already occurring.
Jan 1, 2002 - Remicade (infliximab) is a tumor necrosis factor (TNF) blocker indicated for use in the treatment of Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis.
Jan 1, 2002 - (treprostinil) causes dilation (widening) of the arteries. Also decreases aggregation of platelets (substances in the blood necessary for blood clotting). These effects decrease pressure in the pulmonary artery (artery from the heart to the lungs). Used in the treatment of pulmonary arterial hypertension to diminish symptoms associated with exercise.
Jan 1, 2002 - (cyclosporine) an immunosuppressive agent. Cyclosporine ophthalmic is used to treat chronic dry eye that may be caused by inflammation.
Jan 1, 2002 - Strattera is a selective norepinephrine reuptake inhibitor indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD).
Jan 1, 2002 - (buprenorphine) used as a pain reliever and to treat opiate addiction. An opioid medication similar to other opioids such as morphine, codeine, and heroin however, it produces less euphoric ("high") effects and therefore may be easier to stop taking.
Jan 1, 2002 - (voriconazole) an antifungal medication. Used to treat fungal infections.
Jan 1, 2002 - (sodium oxybate) a central nervous system depressant. The exact way the sodium oxybate works is unknown. Used in the treatment of cataplexy (sudden loss of muscle strength) in patients with narcolepsy. WARNING: Sodium oxybate is also known as GHB, a known street drug of abuse. Because of the potential for abuse of this medication and the serious side effects that may occur, sodium oxybate is only available through the Xyrem Success Program.
Jan 1, 2002 - (tegaserod) increases the action of serotonin (a body chemical) in the intestines. This speeds the movement of stools (bowel movements) through the bowels. Used to treat severe, chronic, irritable bowel syndrome (IBS) in women who have constipation as their main bowel problem, (constipation-predominant). Not been shown to be helpful for men with irritable bowel syndrome.
Jan 1, 2002 - (ezetimibe) is used to reduce the amount of total cholesterol, LDL cholesterol, and apolipoprotein B (a protein needed to make cholesterol) in the blood. Ezetimibe is used with a low cholesterol diet and, in some cases, other cholesterol lowering medications.
Jan 1, 2002 - (ibritumomab) is a protein that specifically targets white blood cells (lymphocytes) in the body. When ibritumomab is attached to a radioactive chemical, such as Indium-111 and Yttrium-90, the radiation is delivered directly to the sites of the lymphoma. Ibritumomab is used in a regimen with rituximab and a radioactive chemical in the treatment of non-Hodgkin’s lymphoma.